Diabetic Retinopathy News and Research

RSS
In the initial stages, people with diabetic retinopathy may not notice their vision changing. Diabetics sometimes experience rapid changes in blood sugar that can temporarily cause blurry vision even when retinopathy is not present. If a person notices a few specks or spots floating in his visual field, this may mean he has developed proliferative diabetic retinopathy, the growth of abnormal new blood vessels on the retina and optic nerve. High blood sugar levels have been linked in studies to retinal blood vessel abnormalities. Blurred vision may occur when the macula--the small area at the center of the retina--swells as it fills with fluid that has leaked from retinal blood vessels. Because damage to the eye often develops slowly, early detection of diabetes and control of blood sugar through diet and medications can make a crucial difference in saving vision.

Effective diabetic retinopathy treatments include laser photocoagulation for early to moderate stages and a microsurgery called vitrectomy for repair of eyes with extensive damage. Injectable and oral medications that act on abnormal blood vessels to control diabetic retinopathy before vision loss occurs are now in development. Early detection would be key to the effectiveness of these treatments, also.
Study: Near-normal glucose control does not delay risk of organ damage in diabetes patients

Study: Near-normal glucose control does not delay risk of organ damage in diabetes patients

Study indicates two treatment strategies can reduce progression of diabetic retinopathy

Study indicates two treatment strategies can reduce progression of diabetic retinopathy

Alimera submits Iluvien NDA for DME to FDA

Alimera submits Iluvien NDA for DME to FDA

Quark Pharmaceuticals' siRNA drug candidates featured in two presentations at Glaucoma & Retinopathies 2010

Quark Pharmaceuticals' siRNA drug candidates featured in two presentations at Glaucoma & Retinopathies 2010

NKI awarded Phase II SBIR grant to develop new ophthalmic screening device for diabetic retinopathy

NKI awarded Phase II SBIR grant to develop new ophthalmic screening device for diabetic retinopathy

New research suggests resveratrol may inhibit pathogenic blood vessel formation

New research suggests resveratrol may inhibit pathogenic blood vessel formation

MicroPulse protocol as effective as ETDRS in treatment of DME: Study

MicroPulse protocol as effective as ETDRS in treatment of DME: Study

Ranibizumab improves vision in patients with visual impairment due to DME: RESTORE study

Ranibizumab improves vision in patients with visual impairment due to DME: RESTORE study

Microplasmin exhibits potential to cure 50% of patients with macular hole

Microplasmin exhibits potential to cure 50% of patients with macular hole

Entelos' T1D PhysioLab platform published in Clinical and Experimental Immunology

Entelos' T1D PhysioLab platform published in Clinical and Experimental Immunology

Latinos have highest rates of eye disease: New research

Latinos have highest rates of eye disease: New research

NormOxys raises $17.5M in Series B financing round

NormOxys raises $17.5M in Series B financing round

Phase 1 clinical trial of OXY111A initiated

Phase 1 clinical trial of OXY111A initiated

Research roundup: Whistleblowers, spreading best practices, Medicare's growth-limiting strategy

Research roundup: Whistleblowers, spreading best practices, Medicare's growth-limiting strategy

Study: When incentive payments are removed, quality of health care suffers

Study: When incentive payments are removed, quality of health care suffers

Telemedical Retinal Image Analysis and Diagnosis technology permits early detection of diabetic retinopathy

Telemedical Retinal Image Analysis and Diagnosis technology permits early detection of diabetic retinopathy

Latinos have higher rates of developing visual impairment than non-Hispanic whites: Researchers

Latinos have higher rates of developing visual impairment than non-Hispanic whites: Researchers

IRIDEX commences commercial shipment of IQ 532 laser systems

IRIDEX commences commercial shipment of IQ 532 laser systems

Researchers participate in national multi-center trial comparing treatments for diabetic macular edema

Researchers participate in national multi-center trial comparing treatments for diabetic macular edema

Ranibizumab eye injections plus laser therapy result in dramatic visual improvement

Ranibizumab eye injections plus laser therapy result in dramatic visual improvement

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.